S. Formenti
Immunology · 2001–2020
A researcher in the Science corpus: 18 papers; trusts 12 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 257 citations into it; #768 of 2,160 by trust here, #402 by citations
- Oncology — 163 citations into it; #570 of 1,698 by trust here, #313 by citations
- Molecular Biology — 122 citations into it
- Radiology, Nuclear Medicine and Imaging — 8 citations into it; #2,673 of 3,265 by trust here, #761 by citations
Whom S. Formenti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Dunn
- M. Smyth
- S. Demaria
- P. Allavena
- Robert Schreiber
- François Ghiringhelli
- D. Pardoll
- Lloyd J. Old
- A. Sica
- A. Tesnière
Who trusts S. Formenti overall
Papers from S. Formenti's perspective
Ordered by how strongly the researchers S. Formenti trusts endorse each paper. Same corpus, a different order for every researcher.
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
- Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
- The Danger Model: A Renewed Sense of Self (Science)
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing (EMBO Journal)
- Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem Cells (Journal of Cell Biology)
- Calreticulin exposure dictates the immunogenicity of cancer cell death (Nature Medicine)
- Cell death modalities: classification and pathophysiological implications (Cell Death and Differentiation)
- Mitochondria and cell death: outer membrane permeabilization and beyond (Nature reviews. Molecular cell biology)
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
Their papers
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity (2017) — 1,580 citations
- Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. (2016) — 757 citations
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (2015) — 3,116 citations
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) — 916 citations
- Using immunotherapy to boost the abscopal effect (2018) — 1,098 citations
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade (2018) — 797 citations
- Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial (2017) — 978 citations
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. (2015) — 613 citations
- Role of Local Radiation Therapy in Cancer Immunotherapy. (2015) — 712 citations
- Consensus guidelines for the detection of immunogenic cell death (2014) — 787 citations
- Combining radiotherapy and cancer immunotherapy: a paradigm shift. (2013) — 1,020 citations
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer (2013) — 638 citations
- Systemic effects of local radiotherapy (2009) — 921 citations
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody (2009) — 1,546 citations
- Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells (2008) — 674 citations
- Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. (2005) — 978 citations
- Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. (2004) — 1,326 citations
- Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. (2001) — 837 citations